Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
If you have cardiovascular risk factors such as high blood pressure, high cholesterol, or a history of heart disease, your healthcare provider may consider GLP-1 shots as part of your treatment plan to help reduce your risk of cardiovascular complications
The cumulative incidence was 6.7% for semaglutide versus 0.8% for the non-GLP-1 RA group over 36 months
There is no published retatrutide-specific discontinuation study, but the mechanism (appetite suppression + metabolic effects) is shared with the class, so similar regain is expected
Novo Nordisk launched it in early January 2026, and the obesity market hasnt looked back
The country's expanding private healthcare sector demonstrates willingness to adopt new obesity pharmacotherapy despite high treatment costs
It can indirectly affect menstrual cycles by regulating blood sugar levels and disrupting hormonal balance, which may lead to changes in menstrual patterns
